Related Experiment Video
Updated: Sep 14, 2026

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Headache and complement C'1-esterase inhibitor deficiency in Vietnamese immigrants living in southern California
Insights
Vietnamese headache patients showed low complement C'1-esterase inhibitor (C1INH) levels. Treatment with danazol normalized C1INH and improved headaches, suggesting an androgen-responsive headache type.
Area of Science:
- Immunology
- Neurology
Background:
- Headache disorders, including migraine and chronic tension-type headache, affect a significant portion of the population.
- The complement system plays a role in inflammatory processes, and its components may be implicated in headache pathophysiology.
- Complement C'1-esterase inhibitor (C1INH) is a key regulator of the complement cascade.
Purpose of the Study:
- To measure C1INH levels in Vietnamese outpatients diagnosed with migraine or chronic tension-type headache.
- To investigate the effect of danazol treatment on C1INH levels and headache symptoms.
- To differentiate this patient group from hereditary or acquired angioedema.
Main Methods:
- Fifty-one Vietnamese outpatients with headache (migraine or chronic tension-type) were evaluated.
- C1INH levels were measured and compared to control subjects.
- A subset of 20 patients received danazol (200 mg daily) for 1-2 months, with subsequent C1INH and C1q/C4d measurements.
Main Results:
- Patients exhibited significantly lower C1INH levels (11 +/- 2 mg/dL) compared to controls (15 +/- 2 mg/dL, p < 0.0001).
- Danazol treatment normalized C1INH levels (16 +/- 2 mg/dL, p < 0.001) and coincided with headache improvement.
- C1q and C4d/C4 ratios remained unchanged after danazol treatment.
Conclusions:
- The findings suggest a potential form of androgen-responsive headache associated with low C1INH levels.
- This condition appears distinct from hereditary or acquired angioedema, lacking typical precipitating factors or family history.
- C1INH levels may serve as a biomarker for a specific headache subtype responsive to androgen therapy.
Abstract:
The objective was to measure complement C'1-esterase inhibitor (C1INH) in a group of Vietnamese outpatients with headache. All 51 patients (7 males and 44 females), with either migraine or chronic tension-type headache, were evaluated during 1994 and 1995. Their ages ranged from 15 to 69 years old (mean age, 37.5 years). They were found to have low levels of C1INH (mean, 11 +/- 2 mg/dL versus control subjects, 15 +/- 2 mg/dL with p < 0.0001). Twenty patients (5 males and 15 females) were treated with a low dose of danazol, 200 mg daily for 1-2 months. The improvement of the headache coincided with the return to normal levels of C1INH in all of our patients (pretreatment, 11 +/- 2 mg/dL versus post-treatment, 16 +/- 2 mg/dL with p < 0.001). The levels of C1q and C4d/C4 ratios did not change as a result of treatment with danazol. Our patients may represent a form of androgen-responsive headache, which is associated with low levels of C1INH, normal levels of C1q and normal C4d/C4. It differentiated them from angioedema (hereditary or acquired form); they had no known precipitating factors or a family history of angioedema.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Related Concept Videos
Viral Meningitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy